In addition, the drug has an ability to decrease the level of the mammalian target of rapamycin [mTOR] protein and reverse the effect of hyperglycemia on the activity of Madin -Derby Canine Kidney cells (MDCK cells) [232]. This evidence concerns the gene MTOR and Hyperglycemia.